Leprosy presenting as immune reconstitution inflammatory syndrome: Proposed definitions and classification

Leprosy Review

Volumn 81, Issue 1, 2010, Pages 59-68

  Deps, Patricia ^a,b   Lockwood, Diana N J ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEPROSY; NEURITIS; REVERSAL REACTION; VIRUS REPLICATION; ADULT; AIDS RELATED COMPLEX; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LEPROSY; MALE; MIDDLE AGED;

EID: 77953158712     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lawn SD, Wilkinson RJ, Lipman MC, Wood R. Immune reconstitution and 'unmasking' of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med, 2008; 177: 680-685.
2. Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus infected person. Clin Infect Dis, 2003; 36: e5-e6.
3. Dhasmana DJ, Dheda K, Ravn P et al. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs, 2008; 68: 191-208.
4. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS, 2004; 18: 1615-1627.
5. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis, 2005; 5: 361-373.
6. Shelburne SA, Visnegarwala F, Darcourt J et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS, 2005; 19: 399-406.
7. Deps PD, Lockwood DN. Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg, 2008; 102: 966-968.
8. Pignataro P, Rocha Ada S, Nery JA et al. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis, 2004; 23: 408-411.
9. Couppie P, Abel S, Voinchet H et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol, 2004; 104: 997-1000.
10. Pereira GA, Stefani MM, Araujo Filho JA et al. Human immunodeficiency virus type 1 (HIV-1) and M. leprae co-infection: HIV-1 subtypes and clinical, immunologic, and histopathologic profiles in a Brazilian cohort. Am J Trop Med Hyg, 2004; 71: 679-684.
11. Visco-Comandini U, Longo B, Cuzzi T et al. Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome. Scand J Infect Dis, 2004; 36: 881-883.
12. Trindade MA, Manini MI, Masetti JH et al. Leprosy and HIVco-infection in five patients. Lepr Rev, 2005; 76: 162-166.
13. Singal A, Mehta S, Pandhi D. Immune reconstitution inflammatory syndrome in an HIV seropositive leprosy patient. Lepr Rev, 2006; 77: 76-80.
14. Narang T, Dogra S, Kaur I. Borderline tuerculoid leprosy with type 1 reaction in an HIV patient - a phenomenon of immune reconstitution. Int J Lep Other Mycobact Dis, 2005; 73: 203-205.
15. Kharkar V, Bhor U, Sunanda M, Khopkar U. Type I reaction presenting as immune reconstitution inflammatory syndrome. Indian J Dermatol Leprol, 2007; 73: 253-256.
16. Talhari C, Machado PR, Ferreira LC, Talhari S. Shifting of the clinical spectrum of leprosy in an HIV-positive patient: a manifestation of immune reconstitution inflammatory syndrome? Lepr Rev, 2007; 78: 151-154.
17. Deps PD, Gripp CG, Madureira BP, Lucas EA. Immune reconstitution syndrome associated with leprosy: two cases. Intern J STD & AIDS, 2008; 19: 135-136.
18. Batista MD, Porro AM, Maeda SM et al. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS. Clin Infect Dis, 2008; 15: e56-e60.
19. Talhari C, Ferreira LCL, Araujo JR et al. Immune reconstitution inflammatory syndrome or upgrading Type 1 reaction? Report of two AIDS patients presenting a shifting from borderline lepromatous leprosy to borderline tuberculoid leprosy. Lepr Rev, 2008; 79: 429-435.
20. Martiniuk F, Rao SD, Rea TH et al. Leprosy as immune reconstitution inflammatory syndrome in HIV positive persons. Emerg Infect Dis, 2007; 13: 1438-1440.
21. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS, 2005; 19: 2109-2116.
22. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub- Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS, 2006; 20: 1605-1612.
23. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS, 2007; 21: 335-341.
24. Battegay M, Nuesch R, Hirschel B, Kaufmann GR. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis, 2006; 6: 280-287.
25. Landay AL, Bettendorf D, Chan E et al. Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced patients with advanced HIV disease. AIDS Res Human Retrov, 2002; 18: 95-102.
26. Bucy RP, Hockett RD, Derdeyn CA et al. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy redistribution from lymphoid tissues. J Clin Invest, 1999; 103: 1391-1398.
27. Trindade MA, Valente NY, Manini MI et al. Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus Type 1 and naive for antiretroviral therapy who exhibited Type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome. J Clin Microbiol, 2006; 44: 4616-4618.
28. Sarno EN, Illarramendi X, Nery JA et al. HIV-M. leprae interaction: can HAART modify the course of leprosy? Public Health Rep, 2008; 123: 206-212.
29. Lucas SB. Human immunodeficiency virus and leprosy. Lepr Rev, 1993; 64: 97-103.
30. Nery JAC, Sampaio EP, Galhardo MCG et al. M. Leprae-HIV co-infection: pattern of immune response in vivo and in vitro. Indian J Lepr, 2000; 72: 457-467.
31. Sampaio EP, Caneshi JR, Nery JA et al. Cellular immune response to Mycobacterium leprae infection in immunedeficiency virus infected individuals. Infect Immun, 1995; 63: 848-854.
32. Bouscarat F, Levacher M, Landman R et al. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS, 1998; 12: 1267-1273.
33. Naafs B. Leprosy and HIV: an analysis. Hansen Int, 2000; 25: 63-66.
34. Moraes MO, Sarno EN, Almeida AS. Cytokine mRNA expression in leprosy reaction: a possible role for IFN-gama and IL-12 in reactions (RR and ENL). Scand J Immunol, 1999; 50: 541-549.